stockrowAlkermes plc (ALKS) vs Lantheus Holdings, Inc. (LNTH)
- Alkermes plc ALKS 44.61 −2.79%
- Lantheus Holdings, Inc. LNTH 100.76 −0.38%
Alkermes plc and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc is the larger, with a market value of $7.5B against $6.6B — 1.1× the size. Alkermes plc has negative trailing earnings, so its P/E is not meaningful; Lantheus Holdings, Inc. trades at 24.3×. Alkermes plc grew revenue faster over the last twelve months: 15.3% against 2.38%. Lantheus Holdings, Inc. has the higher net margin (17.3% vs −0.02%) and the higher return on invested capital (14.6% vs 1.54%). Across the 20 metrics below, Lantheus Holdings, Inc. leads on 16 and Alkermes plc on 4.
Valuation
Profitability
| Metric | ALKS | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.89% | 61.26% | 53.51% |
| Operating margin | 3.66% | 18.62% | 0.00% |
| Net margin | (0.02%) | 17.28% | (2.45%) |
| Free cash flow margin | 13.03% | 26.21% | 0.00% |
| Return on equity | (0.02%) | 21.81% | (0.80%) |
| Return on assets | (0.01%) | 11.41% | (1.67%) |
| Return on invested capital | 1.54% | 14.62% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack